首页> 外文OA文献 >Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance

【2h】

Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance

机译：用磷脂酰肌醇-3-激酶抑制剂治疗癌症：效果增加和克服抵抗力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Marcia N. Paddock; Seth J. Field; Lewis C. Cantley;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance [J] . Marcia N. Paddock, Seth J. Field, Lewis C. Cantley Journal of Lipid Research . 2019,第4期

机译：用磷脂酰肌醇-3-激酶抑制剂治疗癌症：提高疗效并克服耐药性
2. Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance [J] . Paddock Marcia N., Field Seth J., Cantley Lewis C. Journal of Lipid Research . 2019,第4期

机译：用磷脂酰肌醇-3-激酶抑制剂治疗癌症：增加疗效和克服抗性
3. HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance. [J] . Huang X, Wang S, Lee CK, Cancer letters . 2011,第1期

机译：HDAC抑制剂SNDX-275可增强曲妥珠单抗在erbB2过表达的乳腺癌细胞中的功效，并具有克服曲妥珠单抗的潜力。
4. Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer [C] . Hsuan Min Hsu, Chi-YingF. Huang, Chi-Tai Yeh, Molecular Medicine TRI-CON. . 2014

机译：三氟吡嗪，抗精神病药物，抑制癌症干细胞生长，克服肺癌的耐药性
5. Targeting the Colchicine Binding Site on Tubulin to Overcome Multidrug Resistance and Anticancer Efficacy of Selective Survivin Inhibitors [D] . Arnst, Kinsie E. 2018

机译：靶向微管蛋白的血清序列结合位点以克服选择性Survivin抑制剂的多药耐药性和抗癌疗效
6. Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance [O] . Marcia N. Paddock, Seth J. Field, Lewis C. Cantley 2019

机译：用磷脂酰肌醇-3-激酶抑制剂治疗癌症：提高疗效并克服耐药性
7. The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenografts [O] . Ihle, NT, Paine-Murrieta, G, Berggren, MI, 2005

机译：磷脂酰肌醇-3-激酶抑制剂PX-866克服了A-549人非小细胞肺癌异种移植物中对表皮生长因子受体抑制剂吉非替尼的耐药性
8. 99-Technetium Sestamibi Scanning to Predict the Efficacy of Estramustine Phosphate in Overcoming Paclitaxel Resistance in Patients with Advanced Breast Cancer [R] . Volm, M. D. 2004

机译：99-Technetium sestamibi扫描预测雌莫司汀磷酸盐克服晚期乳腺癌患者紫杉醇耐药的疗效

Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance

著录项

引文网络

相似文献

相关主题

期刊订阅